Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May;299(2):261-263.
doi: 10.1148/radiol.2021210348. Epub 2021 Mar 30.

Competitive Advantage of PSMA Theranostics in Prostate Cancer

Hossein Jadvar  1
Affiliations
Editorial

Competitive Advantage of PSMA Theranostics in Prostate Cancer

Hossein Jadvar. Radiology. 2021 May.
No abstract available

PubMed Disclaimer

Figures

Hossein Jadvar is a tenured associate professor of radiology, urology, and biomedical engineering at the University of Southern California. His education includes a PhD in bioengineering (Michigan), MD (Chicago-Pritzker), MPH (Harvard), executive MBA (USC), internship (USCF), diagnostic radiology and nuclear medicine residency (Stanford), and fellowship in PET (Harvard JPNM). He is an NIH-funded physician-scientist with research interests in translational molecular imaging and theranostics in cancer management. He is past president and fellow of ACNM and SNMMI.
Hossein Jadvar is a tenured associate professor of radiology, urology, and biomedical engineering at the University of Southern California. His education includes a PhD in bioengineering (Michigan), MD (Chicago-Pritzker), MPH (Harvard), executive MBA (USC), internship (USCF), diagnostic radiology and nuclear medicine residency (Stanford), and fellowship in PET (Harvard JPNM). He is an NIH-funded physician-scientist with research interests in translational molecular imaging and theranostics in cancer management. He is past president and fellow of ACNM and SNMMI.
See this image and copyright information in PMC

Comment on

  • Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Lawhn-Heath C, Salavati A, Behr SC, Rowe SP, Calais J, Fendler WP, Eiber M, Emmett L, Hofman MS, Hope TA. Lawhn-Heath C, et al. Radiology. 2021 May;299(2):248-260. doi: 10.1148/radiol.2021202771. Epub 2021 Mar 30. Radiology. 2021. PMID: 33787338 Review.

References

    1. Global Burden of Disease Cancer Collaboration ; Fitzmaurice C Abate D, et al. . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2019;5(12):1749–1768. - PMC - PubMed
    1. Imber BS, Varghese M, Ehdaie B, Gorovets D. Financial toxicity associated with treatment of localized prostate cancer. Nat Rev Urol 2020;17(1):28–40. - PMC - PubMed
    1. Jadvar H, Ballas LK. PSMA PET: Transformational change in prostate cancer management?. J Nucl Med 2018;59(2):228–229. - PubMed
    1. Alipour R, Azad A, Hofman MS. Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET? Ther Adv Med Oncol 2019;11:1758835919876828. - PMC - PubMed
    1. Kaittanis C, Andreou C, Hieronymus H, et al. . Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J Exp Med 2018;215(1):159–175.[Published correction appears in J Exp Med 2018;215(1):377.]. - PMC - PubMed

Substances

LinkOut - more resources